Whitehawk Therapeutics Inc
(WHWK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,426 | -21,401 | -15,166 | -10,516 | -4,996 |
| Depreciation Amortization | 13 | 127 | 115 | 103 | 89 |
| Accounts receivable | N/A | N/A | N/A | N/A | -28 |
| Other Working Capital | -181 | 1,536 | 181 | -311 | 617 |
| Other Operating Activity | 1,080 | 854 | 599 | 472 | 389 |
| Operating Cash Flow | $-6,514 | $-18,884 | $-14,271 | $-10,252 | $-3,929 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 50 | N/A | N/A | N/A |
| PPE Investments | -9 | -9 | -7 | -7 | -2 |
| Investing Cash Flow | $-9 | $41 | $-7 | $-7 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 297 | 297 | 297 | 297 |
| Common Stock Issued | 22 | 40,284 | 40,284 | 40,284 | 40,248 |
| Other Financing Activity | 0 | -3,084 | -3,084 | -3,084 | -3,085 |
| Financing Cash Flow | $22 | $37,497 | $37,497 | $37,497 | $37,461 |
| Beginning Cash Position | 20,264 | 1,610 | 1,610 | 1,610 | 1,610 |
| End Cash Position | 13,764 | 20,264 | 24,829 | 28,848 | 35,139 |
| Net Cash Flow | $-6,500 | $18,654 | $23,219 | $27,238 | $33,529 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,514 | -18,884 | -14,271 | -10,252 | -3,929 |
| Capital Expenditure | -9 | -9 | -7 | -7 | -2 |
| Free Cash Flow | -6,522 | -18,892 | -14,278 | -10,259 | -3,931 |